Pfizer and BioNTech's COVID-19 vaccine demonstrates over 90% efficacy as hope builds for an early end to the pandem… https://t.co/7oajgLXB0B
IHS Healthcare and Pharma is now IHS Life Sciences
The IHS Healthcare and Pharma team is happy to announce that we are now IHS Life Sciences. Our new group name better conveys the breadth and depth of our products and services, the companies we work with, and the industries we serve.
Combining our deep knowledge of the industry - integrated access to Pricing and Reimbursement expertise, healthcare economic modeling, and pharmaceutical competitive intelligence - with the extensive economic and analytical capabilities of IHS - technology, supply chain, operational excellence, and modeling - we are able to bring together insights that truly help you, our readers and our clients, work better, smarter, and more profitably.
As of today, you will see our new name here on our blog, on our website www.ihs.com/LifeSciences, and our new twitter handle @IHS4LifeScience.
Thank you for continuing to read our blog and share what you learn with us. We hope you will join us at ISPOR in Montreal this May and in Amsterdam in November to celebrate our new name. We will share details with you as the dates get closer.
- Pfizer and BioNTech's COVID-19 vaccine
- Mixed news on COVID19 vaccines: COVID-19 R&D tracker
- Innovation in Japan’s regenerative sector
- US drug prices could be drastically impacted by Most Favored Nation executive order
- Global healthcare spend to remain stable
- The pandemic pricing dilemma: A COVID-19 vaccine at-cost or for profit?
- US school re-opening decisions in a pandemic environment are complex – data can help
- Trump resurrects International Reference Pricing (IRP) proposal on pharmaceuticals with executive order
RELATED INDUSTRIES & TOPICS
Register from the latest on the progression of the pandemic and the future that lies ahead of us from our Vice Pres… https://t.co/GiqhM1V318
We are expecting major clinical readouts from several key COVID-19 vaccine and therapeutics candidates- our weekly… https://t.co/aIcNOmccrx